# Innova Captab Ltd (INNOVACAP)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹848.3
Day Change: -2.75%
52W High: ₹1020.7
52W Low: ₹622
Market Cap: ₹5,019 Cr

## Valuation
P/E: 35.61
P/B: 4.92
EPS: ₹24.63
Book Value: ₹178.28
Dividend Yield: 0%

## Returns
1Y Return: 12.91%

## Profitability
ROE: 0%
ROCE: 19.86%
Debt/Equity: 0.33
Revenue Growth: 42.3%
Profit Growth: 23.5%
EBITDA Margin: 14.15%
Operating Margin: 12.88%

## About
Innova Captab Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Innova Captab Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Concall Transcript: Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- GuruFocus.com: Innova Captab Ltd (NSE:INNOVACAP) Q4 2026 Earnings Call Highlights: Record Revenue Growth Amid ...

## Access
Current tier: anonymous
More history: Register free to see 4 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:11.526Z
Price History Updated: 2026-05-25T05:31:16.099Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:31:16.099Z
Quant Updated: 2026-05-25T05:31:16.099Z
Sentiment Updated: 2026-05-25T05:31:16.099Z
Financials Status: current
Financials Updated: 2026-05-18T13:30:38.529Z
Financials Last Attempt: 2026-05-18T13:30:38.529Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2020)
Revenue: ₹356 Cr
Operating Profit: ₹41 Cr (OPM 11%)
Net Profit: ₹20 Cr
Tax: ₹25 Cr

## Annual P&L History
Mar 2020: Rev ₹356Cr | PAT ₹20Cr | OPM 11%
Mar 2021: Rev ₹373Cr | PAT ₹28Cr | OPM 14%
Mar 2022: Rev ₹411Cr | PAT ₹34Cr | OPM 13%

## Balance Sheet (Mar 2020)
Total Assets: ₹223 Cr
Total Liabilities: ₹223 Cr
Borrowings: ₹72 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Manoj Kumar Lohariwala, Executive Chairman
- Vinay Kumar Lohariwala, MD & Director
- Lokesh  Bhasin, Chief Financial Officer
- Neeharika  Shukla, Company Secretary & Compliance Officer
- Jayant Vasudeo Rao, Whole-time Director

---
Source: rupiya.io/stocks/innovacap
Disclaimer: For research and education only. Not investment advice.